4
Changes in Ownership
Alkermes plc. Filed Acc 0001127602-24-027044
EVP R&D, Chief Medical Officer sold 58,996 shares at $30.08 ($1,774,576)
- EVP R&D, Chief Medical Officer acquired 43,058 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Hopkinson Craig C. · EVP R&D, Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-11-11 | Exercise or conversion : show line 1 in the form 10b5-1 | +43,058 | $20.03 | $862,452 | 142,296 | D |
| 2024-11-11 | Sale : show line 2 in the form 10b5-1 | −58,996 | $30.08 | $1,774,576 | 83,300 | D |
| Open-market sales · 58,996 sh · avg $30.08 · $1,774,576 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-11-11 | Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Buy) | −43,058 | 129,174 | D |
Loading xslF345X05/form4.xml…